Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)

Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, Antonio Pires, Ann Sullivan, Brian Gazzard, Richard Aspinall, Frances Gotch, Nesrina Imami

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The thymic output of patients receiving highly active antiretroviral therapy (HAART) was assessed by sjTREC (signal joint T cell receptor rearrangement excision circle) analysis to determine the thymic contribution to CD4+ T cell reconstitution during initial therapy and during interleukin 2 (IL-2) and/or Remune supplementation of HAART. Levels of sjTRECs were observed to decline dramatically after the first 4 weeks of HAART and then increased without significant associated changes in CD4+ T cell counts. HAART supplementation with IL-2 was observed to lead to rapid increases in CD4+ T cells that were accompanied by sjTREC decreases. No notable changes in CD4+ T cell counts and sjTRECs were seen in patients receiving HAART supplemented with Remune alone. The results indicate CD4+ T cell maintenance during initial treatment of HIV-1 with HAART and early CD4+ T cell reconstitution of patients receiving IL-2 with HAART is largely due to thymus-independent mechanisms, with the thymus making a limited contribution.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalAIDS Research and Human Retroviruses
Volume19
Issue number2
DOIs
Publication statusPublished - 1 Feb 2003
Externally publishedYes

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)'. Together they form a unique fingerprint.

  • Cite this